AKT1 and colorectal carcinoma: Interestingly, many non-chemotherapeutic drugs exhibited potent anticancer activities against CRC by modulating the cell cycle regulatory and proapoptotic molecules alongside inhibiting the PI3K/Akt/mTOR pathway.